SIGNIFICANCE OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 1 GENE (SERPINE1: 5G>4G) POLYMORPHISM IN CHORIONIC DETACHMENT AND PLACENTAL ABRUPTION IN EARLY PREGNANCY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To estimate the significance of allelic variants of SERPINE1 (PAI-1) gene polymorphism in chorionic detachment and placental abruption in early pregnancy. Subjects and methods. A study group consisted of 67 women with recurrent miscarriage in early pregnancy. A control group included 53 healthy primigravidas. SERPINE1: 5G>4G gene polymorphism was determined using the method of adjacent probes with commercial test systems (OOO «NPO DNK-Tekhnologiya», Russia). Ultrasound study was made employing a 512-channel digital scanner (Siemens SonoLine Elegra, Germany). Results. The average detection time for retrochorial and retroamniotic hematomas was 8.3±0.4 and 12.1±0.5 weeks, respectively. Premature detachment of the chorion and placenta was shown to be associated with the number of 4G alleles of the SERPINE1 (PAI-1) gene in the genotype of a patient. In the 4G/4G genotype, the detachments are 1.5 times more common than those in the 5G/4G genotype. The use of selective antifibrinolytics in combination with antiaggregants and/or low-molecular-weight heparins improves pregnancy outcomes. Conclusion. The 4G allele of the SERPINE1 (PAI-1) gene polymorphism is associated with the development of chorionic and placental detachments in early pregnancy. Moreover, in the 4G/4G genotype, the detachments are 1.5 times more frequently encountered than those in the 5G/4G genotype.

全文:

受限制的访问

作者简介

P. KIRYUSHCHENKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: masha-kirmail@mail.ru

Z. KHODZHAYEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: zhodjaeva@mail.ru

N. TETRUASHVILI

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tetruly@mail.ru

A. DONNIKOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: donnikov@mdl-lab.ru

D. BELOUSOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: slides@narod.ru

E. ANDAMOVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: elena_doctor@mail.ru

M. TAMBOVTSEVA

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: tambovtsevamr@mail.ru

参考

  1. Герштейн Е.С., Кушлинский Н.Е., Лякина Л.Т. и др. Активаторы плазминогена урокиназного и тканевого типов и их ингибитор (PAI-I) в цитозольной фракции при заболеваниях щитовидной железы // Вестн. РАМН. — 2001. — С. 32—33.
  2. Кирющенков П.А., Белоусов Д.М., Александрина О.С. Патогенетическое обоснование тактики ведения отслойки хориона и плаценты на ранних сроках беременности // Гинекология. — 2010. — Т. 12, № 1. — С. 36—39.
  3. Сидельникова В.М., Сухих Г.Т. Невынашивание беременности. — М.: МИА, 2010. — С. 31—43; 380—413.
  4. Тромбогеморрагические осложнения в акушерско-гинекологической практике / Под ред. А.Д. Макацария. — М.: МИА, 2011. — С. 53—57; 635— 656.
  5. Feng Q., Liu Y., Liu K. et al. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation // Placenta. — 2000. — Vol. 21. — P. 184—193.
  6. Iribarren J.L., Jimenez J.J., Hernandez D. et al. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene // Anesthesiology. — 2008. — Vol. 108, N 4. — P. 596—602.
  7. Kohler H.P., Grant P.J. Plasminogen-activator inhibitor type 1 and coronary artery disease // N. Engl. J. Med. — 2000. — Vol. 342, № 24. — P. 1792—1801.
  8. Ma Z., Paek D., Oh C.K. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation // Clin. Exp. Allergy. — 2009. — Vol. 39, № 8. — P. 1136—1144.
  9. Panahloo A., Mohamed-Ali V., Lane A. et al. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene // Diabetes. — 1995. — Vol. 44, № 1. — P. 37—42.
  10. Wiklund P.G., Nilsson L., Ardnor S.N. et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case-control studies based on independent cohorts // Stroke. — 2005. — Vol. 36, № 8. — P. 1661—1665.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##